2L99
| Solution structure of LAK160-P10 | 分子名称: | LAK160-P10 | 著者 | Vermeer, L.S, Bui, T.T, Lan, Y, Jumagulova, E, Kozlowska, J, McIntyre, C, Drake, A.F, Mason, J.A. | 登録日 | 2011-02-03 | 公開日 | 2012-02-01 | 最終更新日 | 2024-05-01 | 実験手法 | SOLUTION NMR | 主引用文献 | The role of proline induced conformational flexibility in determining the antibacterial potency of linear cationic alpha-helical peptides To be Published
|
|
2L9A
| Solution structure of LAK160-P12 | 分子名称: | LAK160-P12 | 著者 | Vermeer, L.S, Bui, T.T, Lan, Y, Jumagulova, E, Kozlowska, J, McIntyre, C, Drake, A.F, Mason, J.A. | 登録日 | 2011-02-03 | 公開日 | 2012-02-01 | 最終更新日 | 2024-05-01 | 実験手法 | SOLUTION NMR | 主引用文献 | The role of proline induced conformational flexibility in determining the antibacterial potency of linear cationic alpha-helical peptides To be Published
|
|
2L96
| Solution structure of LAK160-P7 | 分子名称: | LAK160-P7 | 著者 | Vermeer, L.S, Bui, T.T, Lan, Y, Jumagulova, E, Kozlowska, J, McIntyre, C, Drake, A.F, Mason, J.A. | 登録日 | 2011-02-01 | 公開日 | 2012-02-01 | 最終更新日 | 2024-05-01 | 実験手法 | SOLUTION NMR | 主引用文献 | The role of proline induced conformational flexibility in determining the antibacterial potency of linear cationic alpha-helical peptides To be Published
|
|
6O8S
| Syn-safencin 56 | 分子名称: | Circular bacteriocin, circularin A/uberolysin family | 著者 | Fields, F.R, Lee, S.W. | 登録日 | 2019-03-11 | 公開日 | 2020-05-13 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy. Acs Pharmacol Transl Sci, 3, 2020
|
|
6O8T
| Syn-safencin 96 | 分子名称: | Circular bacteriocin, circularin A/uberolysin family | 著者 | Fields, F.R, Lee, S.W. | 登録日 | 2019-03-11 | 公開日 | 2020-04-15 | 最終更新日 | 2024-05-01 | 実験手法 | SOLUTION NMR | 主引用文献 | Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy. Acs Pharmacol Transl Sci, 3, 2020
|
|
2MTG
| Solution structure of the RRM1 of human LARP6 | 分子名称: | La-related protein 6 | 著者 | Martino, L, Atkinson, A.R, Kelly, G, Conte, M.R. | 登録日 | 2014-08-18 | 公開日 | 2014-12-24 | 最終更新日 | 2024-05-01 | 実験手法 | SOLUTION NMR | 主引用文献 | Synergic interplay of the La motif, RRM1 and the interdomain linker of LARP6 in the recognition of collagen mRNA expands the RNA binding repertoire of the La module. Nucleic Acids Res., 43, 2015
|
|
2MTF
| Solution structure of the La motif of human LARP6 | 分子名称: | La-related protein 6 | 著者 | Martino, L, Salisbury, N.JH, Atkinson, A.R, Kelly, G, Conte, M.R. | 登録日 | 2014-08-18 | 公開日 | 2014-12-24 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Synergic interplay of the La motif, RRM1 and the interdomain linker of LARP6 in the recognition of collagen mRNA expands the RNA binding repertoire of the La module. Nucleic Acids Res., 43, 2015
|
|
6GIK
| |
6RSF
| |
6RSG
| |
4E68
| |
6O8R
| Syn-safencin 24 | 分子名称: | Circular bacteriocin, circularin A/uberolysin family | 著者 | Fields, F.R, Lee, S.W. | 登録日 | 2019-03-11 | 公開日 | 2020-05-13 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy. Acs Pharmacol Transl Sci, 3, 2020
|
|
6O8J
| Syn-safencin | 分子名称: | Circular bacteriocin, circularin A/uberolysin family | 著者 | Fields, F.R, Lee, S.W. | 登録日 | 2019-03-11 | 公開日 | 2020-04-15 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy. Acs Pharmacol Transl Sci, 3, 2020
|
|
6O8P
| Syn-safencin 8 | 分子名称: | Circular bacteriocin, circularin A/uberolysin family | 著者 | Fields, F.R, Lee, S.W. | 登録日 | 2019-03-11 | 公開日 | 2020-05-13 | 最終更新日 | 2024-05-15 | 実験手法 | SOLUTION NMR | 主引用文献 | Synthetic Antimicrobial Peptide Tuning Permits Membrane Disruption and Interpeptide Synergy. Acs Pharmacol Transl Sci, 3, 2020
|
|
6GIL
| NMR structure of temporin B in SDS micelles | 分子名称: | Temporin-B | 著者 | Manzo, G, Mason, J.A. | 登録日 | 2018-05-12 | 公開日 | 2018-06-13 | 最終更新日 | 2024-06-19 | 実験手法 | SOLUTION NMR | 主引用文献 | Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity. Sci Rep, 9, 2019
|
|
6GS5
| |
6GS9
| |
6GIJ
| |
6I9B
| NMR structure of the La module from human LARP4A | 分子名称: | La-related protein 4 | 著者 | Conte, M.R, Martino, L, Atkinson, R.A, Kelly, G, Cruz-Gallardo, I, De Tito, S, Trotta, R. | 登録日 | 2018-11-22 | 公開日 | 2019-03-13 | 最終更新日 | 2024-06-19 | 実験手法 | SOLUTION NMR | 主引用文献 | LARP4A recognizes polyA RNA via a novel binding mechanism mediated by disordered regions and involving the PAM2w motif, revealing interplay between PABP, LARP4A and mRNA. Nucleic Acids Res., 47, 2019
|
|
6I5E
| X-ray structure of apo human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD) | 分子名称: | Bifunctional epoxide hydrolase 2 | 著者 | Abis, G, Kopec, J, Yue, W.W, Conte, M.R. | 登録日 | 2018-11-13 | 公開日 | 2019-05-29 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | 15-deoxy-Delta12,14-Prostaglandin J2inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism. Commun Biol, 2, 2019
|
|
6I5G
| X-ray structure of human soluble Epoxide Hydrolase C-terminal Domain (hsEH CTD)in complex with 15d-PGJ2 | 分子名称: | (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid, 1,2-ETHANEDIOL, Bifunctional epoxide hydrolase 2 | 著者 | Abis, G, Kopec, J, Yue, W.W, Conte, M.R. | 登録日 | 2018-11-13 | 公開日 | 2019-05-29 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | 15-deoxy-Delta12,14-Prostaglandin J2inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism. Commun Biol, 2, 2019
|
|